Shorla Oncology

Clonmel, Ireland

Shorla Oncology develops innovative oncology drugs for women's and pediatric cancers, focusing on life-saving treatments.

$29.6M raised

Feb 2026

Venture - Series Unknown

Health Care Manufacturing Medical Pharmaceutical

Top Investors

Irish Venture Capital Association

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Shorla Oncology

How much funding has Shorla Oncology raised?

Shorla Oncology has raised $29.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.

Who are Shorla Oncology's investors?

Shorla Oncology's investors include Irish Venture Capital Association.

Where is Shorla Oncology headquartered?

Shorla Oncology is headquartered in Clonmel, Ireland.

What does Shorla Oncology do?

Shorla Oncology develops innovative oncology drugs for women's and pediatric cancers, focusing on life-saving treatments.

What stage is Shorla Oncology at?

Shorla Oncology is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 8, 2026.

MLA

"Shorla Oncology — Funding & Investors." VCBacked, February 8, 2026, https://www.vcbacked.co/company/shorla-oncology. Accessed July 4, 2026.

APA

VCBacked. (2026). Shorla Oncology — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/shorla-oncology

Wikipedia (cite web)

{{cite web |title=Shorla Oncology — Funding & Investors |url=https://www.vcbacked.co/company/shorla-oncology |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 8, 2026.